Boehringer Ingelheim Animal Health Canada Inc. contributes to the development of the Centre of Excellence in Veterinary Interventional Medicine and Cardiology at CHUV
Saint-Hyacinthe (Québec) and Burlington (Ontario) – October 5, 2022 – The new Centre of Excellence for Minimally Invasive Procedures (CEMIP), which will be established at Université de Montréal’s Faculty of Veterinary Medicine in Saint-Hyacinthe in fall 2022 will see the addition of advanced interventional cardiology activities thanks to a financial contribution from Boehringer Ingelheim Animal Health Canada Inc.
In support of advancing animal health by promoting minimally invasive procedures and training students in veterinary interventional medicine and cardiology, Boehringer Ingelheim Animal Health Canada has made a financial contribution for the purchase of interventional cardiology equipment for use at CEMIP.
“The lives of animals and humans are interconnected in deep and complex ways, and we know that when animals are healthy, humans are healthier too,” said Dr. Michael Witt, Business Unit Director (Pet), Boehringer Ingelheim Animal Health Canada Inc. “We are pleased to support innovative approaches that help advance animal health and wellbeing, while also investing in veterinary education in Canada.”
The Centre will specialize in treatment and veterinary education in minimally invasive procedures, an increasingly popular medical option that includes interventional radiology and cardiology and is linked with improved patient comfort and shorter recovery times. “Minimally invasive procedures allow us to enter the body through natural routes and reach areas unattainable by standard surgery, such as the inside of the kidneys,” explained Dr. Marilyn Dunn, professor at the Faculty of Veterinary Medicine and also the project’s director.
“The CEMIP will allow for a greater number of patients to be treated and provide a unique training experience for veterinary students servicing a wide range of diagnostic and therapeutic options involving the respiratory, cardiovascular and urinary systems,” Dunn said.
"Thanks to the contribution of Boehringer Ingelheim, the CHUV cardiology team is joining forces with the CEMIP team to offer advanced interventional cardiovascular procedures. Among other things, the equipment acquired will enable us to obtain more realistic, three-dimensional images of the heart's structures in order to better evaluate the therapeutic approach to be recommended," said Dr. Marie-Claude Bélanger, professor of internal medicine and cardiology and Associate Dean of Clinical Affairs and Professional Training at the Faculty of Veterinary Medicine.
The construction start date of the Centre is to be announced soon.
About Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 500 people across Canada. Learn more at www.boehringer-ingelheim.ca.
About the Faculty of Veterinary Medicine of Université de Montréal
Located in Saint-Hyacinthe, in the heart of a region devoted to agri-food research and animal health, the Faculty of Veterinary Medicine (FMV) of Université de Montréal is the only French-language veterinary school in North America. The FMV holds a full accreditation of the American Veterinary Medical Association (AVMA). It is a leader and driving force in animal health and welfare, public health and sustainable development. The FMV is also internationally recognized in animal welfare and pain control, infectious animal diseases, public health and food safety. https://fmv.umontreal.ca/fmv/
About the Centre hospitalier universitaire vétérinaire (CHUV)
The Faculty of Veterinary Medicine’s Centre hospitalier universitaire vétérinaire (CHUV), located in Saint-Hyacinthe, is a unique medical centre with as many as 24,000 visits each year. Offering continuous service, 24 hours a day, 365 days a year, the CHUV is comprised of specialized veterinarians considered experts in their respective fields. These professionals, along with the support of highly qualified technical staff, have access to state-of-the-art equipment, enabling the CHUV to offer a wide range of unique specialized services to veterinarians and pet owners. https://chuv.umontreal.ca/english
Media contacts
Julie Dufour
Communications Advisor
Centre hospitalier universitaire vétérinaire (CHUV), Université de Montréal
450-773-8521, ext. 44018
Merry Garbutt
Corporate Communications
Boehringer Ingelheim (Canada) Ltd.
905-631-4531
Media Contacts
Communications, Media & Public Relations
Corporate Communications
Phone (905) 631-4531
Mobile (647) 637-8265